Pinned Tweet
✅ Milestone: We’ve completed enrollment of the first cohort in our Phase 1b trial of PTM-101 for #pancreaticcancer ahead of expectations! 🚀 Another step forward in advancing localized therapies for #cancer patients.
📣 Full release: businesswire.com/news/home/2…
Next week at #FBW2025, CEO Laura Indolfi joins the Biotech CEO Insights panel 🎤 in Boston. We're proud to be part of the biotech conversation shaping the future of science 🔬 and patient care 💜.
📅 Oct 7–9 | Encore Boston Harbor
#FBW2025 #biotech
bit.ly/4gLoBEE
43
🔬 #ICYMI: Our Phase 1b trial in #pancreaticcancer is rapidly enrolling across the U.S., evaluating a promising new approach to #chemotherapy: an absorbable, long-lasting, high-dose drug patch.
🔗 Learn more: businesswire.com/news/home/2…
24
#ICYMI: We treated the first participant in our Phase 1b clinical trial of PTM-101 for pancreatic #cancer. 🚀 The right anti-cancer drugs exist—but getting it there is the challenge. 💊 Learn how PTM-101 delivers chemotherapy directly to the tumor: businesswire.com/news/home/2…
2
52
🎉 Big news! We’ve treated our first participant with PTM-101, an absorbable, long-lasting high-dose chemotherapy patch, in our clinical trial for #PDAC. It’s a huge step toward powerful, localized cancer care for solid #tumors. 🧬
🔗 Full release: businesswire.com/news/home/2…
Thrilled our CEO @LauraIndolfi will be among featured panelists discussing "Women-led Innovation: Overcoming Challenges as a Female Entrepreneur & Executive in Medtech", taking place at #LSIEurope23 in September. If you’re attending, make sure to connect! #medtech @lsintelligence
A new day, a new panel announced on the #RoadToEurope 🌅
📣 We’re excited to introduce the panel, “Women-led Innovation: Overcoming Challenges as a Female Entrepreneur & Executive in Medtech,” taking place at #LSIEurope23 in Barcelona, Spain.
1
246
PanTher Therapeutics retweeted
@GenRait_Inc, @closedloopai, @HarmonicBionics, @SeasonHealth, @docstationapp, @biostrap, @NucleinDX, @AspiraWH, @Genprex, @OmaivenHealth, @SensiAi, @PanTherTx, @curoxen, @agilonhealth, @neuralink (presence here) & these are ones that I could find handles for.
Thanks @BosBizJournal & @MALifeSciences for featuring our CEO @LauraIndolfi as part of the “Women who lead in Life Sciences” Serie!We are working relentlessly to change the status quo in cancer treatment by bringing the fight directly at the tumor🎯! #AttackingCancerAtTheSource™️
Thrilled to welcome Leslie Sloan as PanTher's SVP of Development & Operations! With a stellar track record in driving execution and delivering successful drug development programs, she adds immense value to our team.
#TherapeuticsOnTarget #AttackingCancerAtTheSource #leadership
🌟Exciting news! PanTher selected for prestigious @MedTechAwards 2023 Program, among 61 startups chosen from 1,150 applicants. Thanks to 400 industry judges for the honor. Thrilled for the journey ahead!🚀
#AttackingCancerAtTheSource™ #TherapeuticsOnTarget #MedTechInnovator
Exciting news! Our CEO, @LauraIndolfi, shared valuable insights on @ProjectMedtech's podcast about raising funds, networking, and her Ted Talk. Give the podcast a listen! #CEO #leadership #TherapeuticsOnTarget🎯
rb.gy/4934o
Excited to be here at #AHPBA23 to see the amazing progress in the field & interact with the community. Looking forward to connecting with surgeons/KOLs regarding our upcoming clinical trial. Reach out to learn more!
@AHPBA #TherapeuticsOnTarget🎯 #AttackingCancerAtTheSource™️
140
We're hiring in #AustinTx!
Interested in a unique opportunity to be part of a clinical-stage startup bringing innovative technology to the oncology market? Apply online: panthertx.com/careers/
#hiring #MovingPanTherForward #TherapeuticsOnTarget🎯#biotechjobs #scientist
Happy 6!!!! Such a special number for us!! Today our team (of 6) had a lunch party to celebrate🎂
- 6 Years with our first employee
- 6 Months with our Director of Ops
- 60 Days with our new Scientist
looking forward to increasing the numbers to celebrate
#DreamTeam #hiringsoon
We look forward to seeing you at @ASCO Gastrointestinal Cancer Symposium #GI23. Stop by the poster session on Friday to view our trial-in-progress poster for our Phase 1 Pancreatic Cancer study.
#TherapeuticsOnTarget🎯 #AttackingCancerAtTheSource™️ #SPHPM
PanTher Therapeutics retweeted
New Year….New City… New Office… @PanTherTx officially set up business in #Austin TX!! 💥Amazed by the great welcome/support we received from the local #MedTech community 🧬🔬🧫🦠💊#MovingPanTherForward #AttackingCancerAtTheSource™️ @CPRITTexas – at Austin, TX
2022 has been a fruitful year, full of goals achieved💥 & progress made 🚀to serve as foundation for more milestones to come. We can't wait to share the fruit of our hard work in Attacking Cancer at the Source™ by bringing #TherapeuticsOnTarget🎯 Looking forward to 2023 🎉🎇
Excited to welcome Chris Johnson to the PanTher Therapeutics #DreamTeam!
Lookout for future roles based in Austin, TX as we continue to grow!
#MovingPanTherForward #TherapeuticsOnTarget🎯 #AttackingCancerAtTheSource™️
1
PanTher Therapeutics retweeted
#CyberMonday = the only time we look forward to a Monday! 😴☕️ To make it even better, all proceeds from your Shop Purple purchase benefit PanCAN! 💜 Get 20% off when you use code CYBER22 at checkout at pcan.at/SPS 🛍
#Boston #Houston #Austin #NYC #TimesSquares💥What whirlwind the last 10days have been!We are thankful for so many things & are closed this week to celebrate them with family & friends…will be back on Monday recharged to bring #TherapeuticsOnTarget🎯 #AttackingCancerAtTheSource™️






















